Benjamin J Samelson-Jones

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Blood

Pediatric blood & cancer

Journal of thrombosis and haemostasis : JTH

Blood advances

University of Pennsylvania

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Pennsylvania

United States

Instructor :: Pediatrics

Publications

Kyumin Lee, Julia Q Chau, Yani B Suber, Anna R Sternberg, Allyson Pishko, Lindsey A George, Vijay Bhoj, Bhavya S Doshi, Benjamin J Samelson-Jones
Enhanced Procoagulant Activity of Select Hemophilia B Causing Factor IX Variants with Emicizumab. Blood (2024)
Benjamin J Samelson-Jones, Juliana C Small, Lindsey A George
Roctavian Gene Therapy for Hemophilia A. Blood advances (2024)
Benjamin J Samelson-Jones, Lindsey A George, Bhavya S Doshi
Coagulation Factor VIII: Biological Basis of Emerging Hemophilia A Therapies. Blood (2024)
Robert Chen, Kavitha Muralidharan, Benjamin J Samelson-Jones
Digital haemophilia: Insights into the use of social media for haemophilia care, research and advocacy. Haemophilia : the official journal of the World Federation of Hemophilia 28 (2) (2022)
Benjamin J Samelson-Jones
A new harmony for hemorrhagic disorders: The Dutch SYMPHONY consortium. Journal of thrombosis and haemostasis : JTH 20 (9) (2022)
Benjamin J Samelson-Jones, Christine J Guelcher, Janice Kuhn, Regina Butler, Gita Massey, Michael F Guerrera, Leslie Raffini
Real-world cost estimates of initiating emicizumab in US patients with haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 27 (4) (2021)
Mary M Robinson, Lindsey A George, Marcus E Carr, Benjamin J Samelson-Jones, Valder R Arruda, John E Murphy, Denis Rybin, Jeremy Rupon, Katherine A High, Stefan Tiefenbacher
Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX-Padua. Journal of thrombosis and haemostasis : JTH 19 (5) (2021)
Amelia R Wilhelm, Nicole A Parsons, Benjamin J Samelson-Jones, Robert J Davidson, Charles T Esmon, Rodney M Camire, Lindsey A George
Activated protein C has a regulatory role in factor VIII function. Blood 137 (18) (2021)
Kaoru Takasaki, David Hehir, Leslie Raffini, Benjamin J Samelson-Jones, Evelyn K Shih, Aleksandra Sarah Dain
Andexanet alfa for reversal of rivaroxaban in a child with intracranial hemorrhage. Pediatric blood & cancer (2021)
Benjamin J Samelson-Jones, Michael R Acord, Leslie Raffini
Comment on: Bivalirudin during thrombolysis with catheter-directed tPA in a heparin-refractory patient: A case report. Pediatric blood & cancer 67 (12) (2020)
Robert A French, Benjamin J Samelson-Jones, Glenn P Niemeyer, Clinton D Lothrop, Elizabeth P Merricks, Timothy C Nichols, Valder R Arruda
Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog model. Blood advances 2 (5) (2019)
Benjamin J Samelson-Jones, Paula M Kramer, Michael Chicka, William T Gunning, Michele P Lambert
MYH9-macrothrombocytopenia caused by a novel variant (E1421K) initially presenting as apparent neonatal alloimmune thrombocytopenia. Pediatric blood & cancer 65 (4) (2017)
Valder R Arruda, Bhavya S Doshi, Benjamin J Samelson-Jones
Novel approaches to hemophilia therapy: successes and challenges. Blood 130 (21) (2017)

Benjamin J Samelson-Jones.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Benjamin J Samelson-Jones